1. DNA topoisomerase-targeting chemotherapeutics: what’s new?

   • Selma M. Cuya
   • Mary-Ann Bjornsti
   • Robert C.A.M. van Waardenburg

   Review Article 20 May 2017 Pages: 1 - 14

   

2. Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

   • Kuhan Kunarajah
   • Stefanie Hennig
   • Andrew S. Moore

   Original Article 25 April 2017 Pages: 15 - 25

   

3. Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?

   • Kuhan Kunarajah
   • Stefanie Hennig
   • Andrew S. Moore

   Erratum 08 June 2017 Pages: 27 - 28

4. Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment

   • Ghassan K. Abou-Alfa
   • Lionel D. Lewis
   • Richard A. Graham

   Original Article 18 May 2017 Pages: 29 - 36

   

5. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy

   • Peng Sun
   • Cong Xue
   • Yan-Xia Shi

   Original Article 22 May 2017 Pages: 37 - 44

   

6. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity

   • M. Bretagne
   • A. Jouinot
   • J. Alexandre

   Original Article 15 May 2017 Pages: 45 - 53

   

7. Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity

   • Osama A. Alkhamees
   • Abdulaziz S. Alroujayee
   • Mohammed M. Ahmed

   Original Article 13 May 2017 Pages: 55 - 64

   

8. Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

   • Tadashi Aoyama
   • Masashi Takano
   • Kenichi Furuya

   Original Article 10 May 2017 Pages: 65 - 69

   

9. Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient

   • Julia Schäfer
   • Lukas Welti
   • Johanna Weiss

   Original Article 12 May 2017 Pages: 71 - 79

   

10. Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy

    • Tsunekazu Mizushima
    • Mutsumi Fukunaga
    • Masaki Mori

    Original Article 16 May 2017 Pages: 81 - 90

    

11. The cardiac glycoside oleandrin induces apoptosis in human colon cancer cells via the mitochondrial pathway

    • Li Pan
    • Yuming Zhang
    • Fan Deng

    Original Article 08 June 2017 Pages: 91 - 100

    

12. Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer

    • G. Milaki
    • I. Messaritakis
    • V. Georgoulias

    Original Article 18 May 2017 Pages: 101 - 108

    

13. ABCC4 functional SNP in the 3′ splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia

    • Hamzeh Mesrian Tanha
    • Soheila Rahgozar
    • Marjan Mojtabavi Naeini

    Original Article 26 May 2017 Pages: 109 - 117

    

14. Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer

    • Yoshiki Hirooka
    • Takuya Ishikawa
    • Hidemi Goto

    Original Article 23 May 2017 Pages: 119 - 125

    

15. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer

    • Mayu Yunokawa
    • Hiroshi Yoshida
    • Kenji Tamura

    Original Article 24 May 2017 Pages: 127 - 134

    

16. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis

    • Xue Zhang
    • Jia-Fu Yin
    • Xue-Mei Chen

    Original Article 05 June 2017 Pages: 135 - 149

    

17. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel

    • Gregoriy Smiyun
    • Olga Azarenko
    • Mary Ann Jordan

    Original Article 31 May 2017 Pages: 151 - 164

    

18. Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women’s cancers

    • Cody J. Peer
    • Jung-Min Lee
    • William D. Figg

    Original Article 02 June 2017 Pages: 165 - 175

    

19. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia

    • Nasrin Dehghan-Nayeri
    • Peyman Eshghi
    • Ahmad Gharehbaghian

    Original Article 05 June 2017 Pages: 177 - 185

    

20. Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer

    • Sungwoo Park
    • Byung Woog Kang
    • Sun Ah Lee

    Original Article 08 June 2017 Pages: 187 - 193

    

21. Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

    • Kentaro Sudo
    • Ryusuke Hara
    • Taketo Yamaguchi

    Original Article 08 June 2017 Pages: 195 - 202

    

22. Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan

    • Goshi Nishimura
    • Osamu Shiono
    • Nobuhiko Oridate

    Original Article 08 June 2017 Pages: 203 - 207

    

23. Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients

    • Bum Jun Kim
    • Jaewon Hyung
    • Heung-Moon Chang

    Original Article 08 June 2017 Pages: 209 - 215

    

24. Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms

    • Tristan M. Sissung
    • Cody J. Peer
    • William D. Figg

    Short Communication 09 May 2017 Pages: 217 - 221